Yet GSK is clearly healing from its multiple comorbidities — the worst of which was the (now largely resolved) legal overhang related to heartburn medicine Zantac. Chief executive Emma Walmsley also ...
We recently compiled a list of the 10 Companies Jump on Better Earnings, Outlook. In this article, we are going to take a ...
6hon MSN
Harvey Jones hails the brilliant long-term performance of the AstraZeneca share price, but wonders whether the FTSE 100's ...
CFRA analyst Wan Nurhayati revised the price target for GlaxoSmithKline (NYSE:GSK) shares, reducing it to $40.00 from the ...
UK's FTSE 100 firmed on Wednesday after two straight days of losses, buoyed by gains in shares of heavyweight GSK and gold ...
The stock market extended its winning streak on Wednesday, closing firmer as investors seemed to have already priced in the ...
IPOBIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 06.02.2025 / 07:00 CET/CEST__________THIS IS A RESTRICTED ...
Barclays raises British American Tobacco price target to 3,550 (3,250) pence - 'overweight' Bank of America cuts Rolls-Royce price target to 830 (850) pence - 'buy' Barclays cuts Hiscox price target ...
FTSE Climbs on rate cut hopes amid inflation heat; GSK Soars 7.6%. US trade gap widens.
Learn more about whether Catalyst Pharmaceuticals, Inc. or Ionis Pharmaceuticals, Inc. is a better investment based on AAII's ...
European shares reversed an earlier decline to finish higher, powered in by part by a surge in healthcare stocks. In New York ...
CAR giants believe they are close to convincing the Government to soften some of its tough net zero rules. Representatives ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback